At Neuro4D 2026 in Mainz, Noselab contributed to discussions on emerging challenges and future directions in CNS research, highlighting the potential of nasal fluid as a minimally invasive source of CNS-related molecular information.

At CNS Discovery Xchange 2026 in Boston, Noselab showcased the diagnostic potential of nasal fluid as a source of brain-derived molecular information. Through its keynote and roundtable discussion, the company highlighted the Brain–Nose Interface as a promising minimally invasive approach for advancing CNS biomarker discovery, patient stratification, and longitudinal monitoring.

Noselab showcased new scientific findings at AD/PD 2026, demonstrating the potential of nasal fluid as a novel source of brain-derived molecular information.